tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Cumberland Pharmaceuticals Inc

CPIX
Add to Watchlist
6.680USD
-0.050-0.74%
Close 07-31 16:00（ET）Quotes delayed by 15 min
99.91MMarket Cap
LossP/E TTM

Cumberland Pharmaceuticals Inc

6.680
-0.050-0.74%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CPIX Financials

See Cumberland Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cumberland Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
44.52M
17.57%
EPS(YoY)
-0.19
58.57%
Analyst Rating
HOLD
2025/12/09
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-361.37%-0.22
28.82%-0.10
-18.07%-0.13
35.62%-0.05
160.94%0.08
69.34%-0.14
-49.52%-0.11
-226.90%-0.08
-1131.76%-0.14
-162.12%-0.44
---0.07
--0.06
--0.01
---0.17
----
----
----
----
----
----
Revenue
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
-5.65%9.06M
Net Profit
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
233.79%1.23M
Net Margin
-422.79%-34.40%
42.68%-10.44%
-38.95%-23.50%
39.40%-6.78%
147.60%10.66%
72.95%-18.22%
-60.47%-16.92%
-241.40%-11.20%
-1298.72%-22.39%
-149.92%-67.38%
---10.54%
--7.92%
--1.87%
---26.96%
----
----
----
----
----
----
Gross Margin
-17.79%65.14%
13.61%76.21%
3.17%75.90%
0.97%72.15%
15.87%79.25%
-5.34%67.07%
3.85%73.57%
-5.22%71.46%
-6.46%68.39%
37.12%70.86%
--70.84%
--75.40%
--73.11%
--51.68%
----
----
----
----
----
----
Debt to assets ratio
-1.49%7.38%
-66.25%6.82%
-62.07%7.95%
-62.34%7.72%
-62.02%7.49%
29.28%20.21%
42.37%20.97%
39.31%20.49%
9.85%19.73%
-10.33%15.63%
--14.73%
--14.71%
--17.96%
--17.43%
----
----
----
----
----
----
Income Statement
Revenue
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
-5.65%9.06M
Operating profit
-342.22%-3.13M
25.56%-1.37M
-15.98%-1.97M
27.20%-747.48K
169.12%1.29M
35.03%-1.84M
9.22%-1.69M
-4591.40%-1.03M
-22.04%-1.87M
20.75%-2.84M
-464.99%-1.87M
101.58%22.86K
-121.34%-1.53M
-9.95%-3.58M
132.71%511.41K
-17.06%-1.45M
-208.51%-692.00K
-110.49%-3.25M
-29.35%-1.56M
21.84%-1.24M
Net Profit
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
233.79%1.23M
Balance Sheet
Current assets
2.86%32.79M
1.67%37.06M
-15.03%29.94M
-12.30%31.21M
-11.96%31.88M
2.07%36.45M
-15.64%35.24M
-18.53%35.58M
-17.36%36.21M
-22.14%35.71M
-15.03%41.77M
-0.17%43.67M
-3.38%43.81M
0.40%45.87M
4.12%49.16M
-6.28%43.75M
-8.18%45.34M
-8.57%45.69M
-3.43%47.22M
2.02%46.68M
Total current liabilities
35.14%34.49M
16.20%36.74M
-21.80%24.31M
-3.17%23.97M
-3.43%25.52M
13.01%31.62M
13.76%31.09M
-8.17%24.76M
2.79%26.43M
-2.09%27.98M
7.99%27.33M
11.16%26.96M
4.68%25.71M
48.24%28.58M
41.02%25.31M
30.06%24.25M
7.48%24.56M
-24.89%19.28M
-25.03%17.95M
-17.73%18.65M
Total assets
1.51%71.00M
1.64%76.82M
-14.14%65.90M
-13.52%67.91M
-14.20%69.94M
-7.57%75.58M
-12.54%76.75M
-12.15%78.52M
-8.90%81.51M
-12.00%81.78M
-3.33%87.75M
-3.40%89.38M
-7.48%89.47M
10.02%92.93M
3.66%90.78M
4.13%92.52M
3.59%96.70M
-12.44%84.46M
-8.79%87.57M
-8.89%88.85M
Total liabilities
19.47%49.69M
-1.43%52.28M
-23.30%40.10M
-23.36%40.23M
-23.43%41.60M
0.99%53.04M
0.35%52.28M
-0.10%52.49M
1.68%54.32M
-7.79%52.52M
-0.36%52.10M
-1.45%52.54M
-4.44%53.42M
36.06%56.95M
27.76%52.29M
29.90%53.31M
20.30%55.90M
-15.59%41.86M
-15.03%40.92M
-16.43%41.04M
Total equity
-24.83%21.30M
8.86%24.54M
5.44%25.80M
6.33%27.68M
4.23%28.34M
-22.95%22.55M
-31.37%24.47M
-29.33%26.03M
-24.58%27.19M
-18.66%29.26M
-7.37%35.66M
-6.04%36.84M
-11.63%36.05M
-15.56%35.97M
-17.48%38.49M
-18.00%39.20M
-12.98%40.79M
-9.11%42.60M
-2.50%46.65M
-1.25%47.81M
Cash Flow Statement
Net operating income
-90.07%387.02K
-99.84%3.02K
-60.64%187.18K
198.61%843.80K
282.46%3.90M
83.12%1.90M
-61.55%475.50K
-116.34%-855.66K
-50.66%-2.14M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
149.80%3.64M
540.11%2.64M
5.91%2.33M
-111.67%-150.50K
392.30%1.46M
-1059.30%-598.79K
-20.76%2.20M
Net investment
95.02%-61.17K
-11363.83%-3.07M
-464.29%-690.84K
710.77%285.86K
-2010.79%-1.23M
-110.29%-26.81K
299.47%189.64K
51.65%-46.80K
66.65%-58.19K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2291.39%-640.77K
728.95%680.80K
-255.76%-172.59K
-4153.90%-13.54M
91.52%-26.80K
83.81%-108.24K
75.97%-48.51K
Net financing
86.19%-763.30K
50.54%-681.74K
27.93%-386.88K
51.29%-150.80K
-328.19%-5.53M
7.31%-1.38M
39.18%-536.84K
90.55%-309.57K
236.12%2.42M
46.52%-1.49M
55.67%-882.60K
-171.12%-3.28M
-145.41%-1.78M
-278.19%-2.78M
-619.86%-1.99M
36.52%-1.21M
401.86%3.92M
69.75%-735.30K
141.84%383.02K
16.04%-1.90M

FAQs

What is the total revenue of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 44.52M, with a year-on-year change of 37.87M.

What are the current assets of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its current assets were 37.06M, with a year-on-year change of 1.67.

What are the total assets of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its total assets of Cumberland Pharmaceuticals Inc were 76.82M, with a year-on-year change of 1.64.

What are the total liabilities of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Cumberland Pharmaceuticals Inc were 52.28M, with a year-on-year change of -1.43.

What is the total equity of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its total equity of Cumberland Pharmaceuticals Inc was 24.54M, with a year-on-year change of 8.86.

What is the net operating income of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Cumberland Pharmaceuticals Inc was -2.79M, with a year-on-year change of 56.59.

What is the net investment of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its net investment of Cumberland Pharmaceuticals Inc was -4.71M, with a year-on-year change of -8236.82.

What is the net financing of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its net financing of Cumberland Pharmaceuticals Inc was -6.75M, with a year-on-year change of -3525.79.

What is the Earnings Per Share (EPS) of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.19, with a year-on-year change of 58.57.

What is the net income of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its net income was -2.84M, with a year-on-year change of 56.23.

What is the net margin of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -6.43, with a year-on-year change of 62.19.

What is the gross margin of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 75.71, with a year-on-year change of 8.69.

What is the debt-to-asset ratio of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 6.82, with a year-on-year change of -66.25.

What is the Return on Equity (ROE) of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -11.88, with a year-on-year change of 51.90.

What is the Return on Assets (ROA) of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -3.76, with a year-on-year change of 54.10.

What is the operating profit of Cumberland Pharmaceuticals Inc?

According to Cumberland Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -2.79M, with a year-on-year change of 56.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy